Advances in Colorectal Cancer Screening Strategies in Clinical Practice - Episode 3
Shared Decision-Making in Colorectal Cancer Screening
Doctors share tactics to boost colorectal screening: compare colonoscopy vs stool tests, address fears, and prevent cancer before symptoms.
In’ Shared Decision-Making in Colorectal Cancer Screening’, the panelists focus on practical strategies for engaging patients in colorectal cancer screening conversations and improving screening uptake. The faculty discuss how to present screening options—colonoscopy, stool-based testing, and other modalities—by outlining the risks, benefits, and trade-offs of each approach. Emphasis is placed on shared decision-making, addressing patient concerns about invasiveness, preparation, and potential complications while reinforcing the importance of early detection and cancer prevention. The speakers also highlight the role of stool DNA testing and FIT in average-risk patients and clarify expectations for follow-up colonoscopy after a positive result. Finally, the discussion underscores the importance of high-quality colonoscopy reporting and appropriate follow-through to ensure effective colorectal cancer prevention.
Our next episode, ’Colorectal Cancer Screening Modalities and Implementation Strategies,’ further explores the expanding range of colorectal cancer screening options, including FIT, stool DNA/RNA tests, and emerging blood-based assays. The panelists highlight the performance characteristics, intervals, and appropriate use for each screening option. The discussion emphasizes patient-centered selection, the necessity of colonoscopy for symptomatic or high-risk individuals, and the importance of tracking, follow-up, and updated surveillance intervals to ensure timely and effective screening.
